Skip to main content
Erschienen in: European Radiology 6/2012

01.06.2012 | Gastrointestinal

Evaluation of the anti-peristaltic effect of glucagon and hyoscine on the small bowel: comparison of intravenous and intramuscular drug administration

verfasst von: Andreas Gutzeit, Christoph A. Binkert, Dow-Mu Koh, Klaus Hergan, Constantin von Weymarn, Nicole Graf, Michael A. Patak, Justus E. Roos, Marcus Horstmann, Sebastian Kos, Simone Hungerbühler, Johannes M. Froehlich

Erschienen in: European Radiology | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate prospectively duration and effectiveness of aperistalsis achieved by glucagon(GLU) or hyoscine N-butylbromide(HBB) following various administration routes.

Materials and methods

Six volunteers underwent Magnetic Resonance Imaging (MRI) after standardized oral preparation in random order five separate MR examinations with both spasmolytic agents (HBB intravenous(i.v.) or intramuscular(i.m.), GLU i.v. or i.m., and a combined scheme). The MR protocol included a sagittal 2D cross-section of the small bowel with a temporal resolution of 0.55 s acquired over 60 to 90 min. To quantify bowel motility, small bowel cross-sectional areas were summated over time.

Results

The anti-peristaltic i.v. effects of HBB and glucagon started on average after 85 s/65 s and ended after 21 min/23.3 min, respectively. By comparison, the anti-peristaltic effects of i.m. HBB and glucagon started significantly later 5.1/11.6 min (P = 0.001; Wilcoxon signed ranks test) and lasted for 17.7/28.2 min with greater inter-individual differences (P = 0.012; Brown-Forsythe test). The combined scheme resulted in a rapid onset after 65 s with effect duration of 31 min.

Conclusion

Anti-peristaltic effects on the small bowel are drug dependant, i.e., their onset is faster and more reliable when administering i.v. than i.m.. Combining i.v. GLU with i.m. HBB provides an early onset of effect, sustained spasmolysis and the highest degree of motility impairment.

Key Points

Anti-persitaltic agents are widely used before various diagnostic procedures of the abdomen.
The combination of iv-glucagon with im-hyoscine provides reliable spasmolysis with early onset.
Intravenous spasmolysis is more reliable compared to intramuscular administration.
Intravenous glucagon has a prolonged spasmolytic effect compared to intravenous hyoscine.
Literatur
1.
Zurück zum Zitat Husebye E (1999) The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol Motil 11:141–161PubMedCrossRef Husebye E (1999) The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol Motil 11:141–161PubMedCrossRef
2.
Zurück zum Zitat Kozak RI, Bennett JD, Brown TC, Lee TY (1994) Reduction of bowel motion artifact during digital subtraction angiography: a comparison of hyoscine butylbromide and glucagon. Can Assoc Radiol J 45:209–211PubMed Kozak RI, Bennett JD, Brown TC, Lee TY (1994) Reduction of bowel motion artifact during digital subtraction angiography: a comparison of hyoscine butylbromide and glucagon. Can Assoc Radiol J 45:209–211PubMed
3.
Zurück zum Zitat Laniado M, Grönewäller E, Kopp AF et al (1997) The value of hyoscine butylbromide in abdominal MR imaging with and without oral magnetic particles. Abdom Imaging 22:381–388PubMedCrossRef Laniado M, Grönewäller E, Kopp AF et al (1997) The value of hyoscine butylbromide in abdominal MR imaging with and without oral magnetic particles. Abdom Imaging 22:381–388PubMedCrossRef
4.
Zurück zum Zitat Johnson W, Taylor MB, Carrington BM, Bonington SC, Swindell R (2007) The value of hyoscine butylbromide in pelvic MRI. Clin Radiol 62:1087–1093PubMedCrossRef Johnson W, Taylor MB, Carrington BM, Bonington SC, Swindell R (2007) The value of hyoscine butylbromide in pelvic MRI. Clin Radiol 62:1087–1093PubMedCrossRef
5.
Zurück zum Zitat Martí-Bonmatí L, Graells M, Ronchera-Oms CL (1996) Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen: a comparative evaluation of three drugs. Abdom Imaging 2:309–313CrossRef Martí-Bonmatí L, Graells M, Ronchera-Oms CL (1996) Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen: a comparative evaluation of three drugs. Abdom Imaging 2:309–313CrossRef
6.
Zurück zum Zitat Wagner M, Klessen C, Rief M et al (2008) High-resolution T2-weighted abdominal magnetic resonance imaging using respiratory triggering: impact of butylscopolamine on image quality. Acta Radiol 49:376–382PubMedCrossRef Wagner M, Klessen C, Rief M et al (2008) High-resolution T2-weighted abdominal magnetic resonance imaging using respiratory triggering: impact of butylscopolamine on image quality. Acta Radiol 49:376–382PubMedCrossRef
7.
Zurück zum Zitat Mayo KE, Miller LJ, Bataille D et al (2003) International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev 55:167–194PubMedCrossRef Mayo KE, Miller LJ, Bataille D et al (2003) International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev 55:167–194PubMedCrossRef
8.
Zurück zum Zitat Dubé PE, Brubaker PL (2007) Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators. Am J Physiol Endocrinol Metab 293:E460–E465PubMedCrossRef Dubé PE, Brubaker PL (2007) Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators. Am J Physiol Endocrinol Metab 293:E460–E465PubMedCrossRef
9.
Zurück zum Zitat Tytgat GN (2008) Hyoscine butylbromide—a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures. Curr Med Res Opin 24:3159–3173PubMedCrossRef Tytgat GN (2008) Hyoscine butylbromide—a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures. Curr Med Res Opin 24:3159–3173PubMedCrossRef
10.
Zurück zum Zitat Huizinga JD, McKay CM, White EJ (2006) The many facets of intestinal peristalsis. Am J Physiol Gastrointest Liver Physiol 290:G1347–G1349PubMedCrossRef Huizinga JD, McKay CM, White EJ (2006) The many facets of intestinal peristalsis. Am J Physiol Gastrointest Liver Physiol 290:G1347–G1349PubMedCrossRef
11.
Zurück zum Zitat Stone AJ, Browne JE, Lennon B, Meaney JF, Fagan AJ (2011) Stone Quantification of accuracy of ADC measurements from Whole-body DWIBS. Proc Intl Soc Mag Reson Med 19:836 Stone AJ, Browne JE, Lennon B, Meaney JF, Fagan AJ (2011) Stone Quantification of accuracy of ADC measurements from Whole-body DWIBS. Proc Intl Soc Mag Reson Med 19:836
12.
Zurück zum Zitat Rowland-Hill CA, Loveday EJ, Thomas ML (1989) A comparison of the value of hyoscine butylbromide and glucagon on aorto iliac intravenous digital subtraction. Vasa 18:301–303PubMed Rowland-Hill CA, Loveday EJ, Thomas ML (1989) A comparison of the value of hyoscine butylbromide and glucagon on aorto iliac intravenous digital subtraction. Vasa 18:301–303PubMed
13.
Zurück zum Zitat Rogalla P, Lembcke A, Rückert JC et al (2005) Spasmolysis at CT colonography: butyl scopolamine versus glucagon. Radiology 236:184–188PubMedCrossRef Rogalla P, Lembcke A, Rückert JC et al (2005) Spasmolysis at CT colonography: butyl scopolamine versus glucagon. Radiology 236:184–188PubMedCrossRef
14.
Zurück zum Zitat Gutzeit A, Patak MA, von Weymarn C et al (2010) Feasibility of small bowel flow rate measurement with MRI. J Magn Reson Imaging 32:345–351PubMedCrossRef Gutzeit A, Patak MA, von Weymarn C et al (2010) Feasibility of small bowel flow rate measurement with MRI. J Magn Reson Imaging 32:345–351PubMedCrossRef
15.
Zurück zum Zitat Froehlich JM, Daenzer M, von Weymarn C et al (2009) Aperistaltic effect of hyoscine N-butylbromide versus glucagon on the small bowel assessed by magnetic resonance imaging. Eur Radiol 19:1387–1393PubMedCrossRef Froehlich JM, Daenzer M, von Weymarn C et al (2009) Aperistaltic effect of hyoscine N-butylbromide versus glucagon on the small bowel assessed by magnetic resonance imaging. Eur Radiol 19:1387–1393PubMedCrossRef
16.
Zurück zum Zitat Froehlich JM, Patak MA, von Weymarn C, Juli CF, Zollikofer CL, Wentz KU (2005) Small bowel motility assessment with magnetic resonance imaging. J Magn Reson Imaging 21:370–375PubMedCrossRef Froehlich JM, Patak MA, von Weymarn C, Juli CF, Zollikofer CL, Wentz KU (2005) Small bowel motility assessment with magnetic resonance imaging. J Magn Reson Imaging 21:370–375PubMedCrossRef
17.
Zurück zum Zitat Wakamiya M, Furukawa A, Kanasaki S, Murata K (2011) Assessment of small bowel motility function with cine-MRI using balanced steady-state free precession sequence. J Magn Reson Imaging 33:1235–1240PubMedCrossRef Wakamiya M, Furukawa A, Kanasaki S, Murata K (2011) Assessment of small bowel motility function with cine-MRI using balanced steady-state free precession sequence. J Magn Reson Imaging 33:1235–1240PubMedCrossRef
Metadaten
Titel
Evaluation of the anti-peristaltic effect of glucagon and hyoscine on the small bowel: comparison of intravenous and intramuscular drug administration
verfasst von
Andreas Gutzeit
Christoph A. Binkert
Dow-Mu Koh
Klaus Hergan
Constantin von Weymarn
Nicole Graf
Michael A. Patak
Justus E. Roos
Marcus Horstmann
Sebastian Kos
Simone Hungerbühler
Johannes M. Froehlich
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 6/2012
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-011-2366-1

Weitere Artikel der Ausgabe 6/2012

European Radiology 6/2012 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.